In VivoDevice Transactions Continuing the downward trend in financing over the past several quarters, the device industry collected $1.2 billion in Q2 funding, a 48% decrease from Q1's $2.3 billion total. It
ScripBiopharmaceutical start-up companies – firms founded four years ago or less – raised fewer dollars during the third quarter than during the prior quarter despite Roivant Sciences GMBH 's massive $1
In VivoDevice Transactions The device industry pulled in $1.5 billion in financing during the second quarter of 2016, a 15% drop from Q1's $1.8 billion. Once again, debt offerings played a big role, represen
In VivoSOURCE: Strategic Transactions